Home > Insider Trading > Filing (0001127602-10-008723)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1224662	A John Kraeutler	3471 River Hills Drive Cincinnati OH 45244	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-15	19,608	$23.66	175,260	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

As a result of technological limitations of the EDGAR system, this Form 4 is being filed in two parts: this current reportand another Form 4 of the reporting party filed on the same date. To minimize confusion, only the current report includesthe information in Table II. As such, both this Form and the other Form 4 of the reporting party filed on the same dateshould be read in tandem.
As a result of technological limitations of the EDGAR system, this Form 4 is being filed in two parts: this current reportand another Form 4 of the reporting party filed on the same date. To minimize confusion, only the other report of thereporting party filed on the same date includes the information in Table II. As such, both this Form and the other Form 4 ofthe reporting party filed on the same date should be read in tandem.
Prices ranged from $23.50 to $23.76 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a securityholder of the issuer.
Sales made pursuant to a Rule 10b5-1 trading plan.